Compliance-57 (4): Prior intimation to the beginning of the quarter
Filed with BSE · · 1 page · English
We kindly request you to take the above said on record. DR K KOTESWARA RAO CHAIRMAN & MANAGING DIRECTOR Plot 69 & 70 IDA Bollaram, Sangareddy District – 502 325, Telangana, India Ph: +91-40-65589499 Fax: +91-8458-279755 Web: www.transgenebiotek.com Email: [email protected], CIN No: L85195AP1990PLC011065
Transgene Biotek Limited on 6ix
Earlier from Transgene Biotek
- Compliance-57 (5): intimation after the end of quarter
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Transgene Biotek Limited. Press Release Oct 11 2025
- Statement Of Deviation & Variation
- Transgene Biotek Limited. Press Release Sep 24 2025
Later from Transgene Biotek
- Declaration Under Clause 36 Of Listing Agreement With BSE - Intimation About The Filing At NCLT (Hyderabad) Bench By M/S BABAJI NETHRALAYYA PRIVATE LTD
- Transgene Biotek Limited. Press Release Oct 17 2025
- Board Meeting Intimation for Intimation Of The Board Meeting To Be Held On Friday, 14Th November, 2025
- Transgene Biotek Limited. Press Release Oct 31 2025
- Board Meeting Outcome for Outcome Of Board Meeting Held On November 14, 2025.
Follow Transgene Biotek into a list and get an email when it puts out news.
Follow Transgene Biotek